Efficacy and Tolerability of a Triple Acid‐Containing Serum Combined With 0.1% Adapalene in Mild‐to‐Moderate Acne Vulgaris: A Randomized, Open‐Label Controlled Trial
Journal of Cosmetic Dermatology · 2026-05 · 25 (5)
DOI: 10.1111/jocd.70929 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Cosmetic Dermatology, online erschienen am 19.05.2026. Verfasst von Jing LYu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Chongqing Hospital of Traditional Chinese Medicine, Chongqing, China. Hauptthemen laut MEDLINE: Acne Vulgaris, Adapalene, Dermatologic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: DR. WU Acne Research Fund..
Abstract (Originalsprache)
Background
Although topical retinoids are first‐line therapy for mild‐to‐moderate acne, treatment‐related irritation often limits adherence to long‐term therapy. However, dermocosmetic adjuncts may improve treatment outcomes and tolerability.
Aim
To assess the efficacy and tolerability of a triple acid‐containing serum (TAS) in mild‐to‐moderate acne.
Methods
An 8‐week, open‐label, randomized controlled trial of 41 patients with mild‐to‐moderate acne was performed. The participants received either TAS + adapalene gel (AG) (treatment group) or AG alone (control group) for 4 weeks, followed by a 4‐week maintenance phase in which AG was discontinued, and TAS was continued only in the experimental group. Lesion counts, Investigator Global Assessment (IGA), microcomedone counts, skin physiological parameters, and VISIA‐CR were performed at baseline and 2, 4, and 8 weeks.
Results
A significantly greater reduction in noninflammatory, inflammatory, and total lesions, IGA scores, and microcomedone counts was observed in the experimental group. The control group showed rebound worsening after AG withdrawal. Improvements in skin physiological parameters were observed in both groups, although without statistical significance. Mild and transient adverse events occurred.
Conclusion
TAS in combination with AG was shown to improve mild‐to‐moderate acne with good tolerability and may effectively reduce the recurrence rate when applied as a maintenance treatment post‐AG.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Chongqing Hospital of Traditional Chinese Medicine, Chongqing, China.
ORCID-Profile: Jiajia Li
Förderung
- DR. WU Acne Research Fund.
Zitieren
APA
LYu, J., Li, J., Jiang, Y., Wang, S., & Diao, Q. (2026). Efficacy and Tolerability of a Triple Acid‐Containing Serum Combined With 0.1% Adapalene in Mild‐to‐Moderate Acne Vulgaris: A Randomized, Open‐Label Controlled Trial. Journal of Cosmetic Dermatology, 25(5). https://doi.org/10.1111/jocd.70929
Vancouver
LYu J, Li J, Jiang Y, Wang S, Diao Q. Efficacy and Tolerability of a Triple Acid‐Containing Serum Combined With 0.1% Adapalene in Mild‐to‐Moderate Acne Vulgaris: A Randomized, Open‐Label Controlled Trial. Journal of Cosmetic Dermatology. 2026;25(5). doi:10.1111/jocd.70929
BibTeX
@article{LYu2026,
author = {LYu, Jing and Li, Jiajia and Jiang, Yang and Wang, Sha and Diao, Qingchun},
title = {Efficacy and Tolerability of a Triple Acid‐Containing Serum Combined With 0.1% Adapalene in Mild‐to‐Moderate Acne Vulgaris: A Randomized, Open‐Label Controlled Trial},
journal = {Journal of Cosmetic Dermatology},
year = {2026},
volume = {25},
number = {5},
doi = {10.1111/jocd.70929}
}
EUVIMED